performance are as follows: Sales Revenue Sales revenue for Q2/2017 of 269.33 million baht shows an increase of 99.98 million baht or 59.04% y-o-y. Cost of sales of 172.40 million baht shows an increase of
Company Unit : Million Baht For the 3 months Change between QoQ Change between YoY For the 9 months Change between YoY Q3/17 Q1/17 Q2/16 Amount % Amount % Q2/17 Q2/16 Amount % Revenues from medical services
March 31 2017 2018 Changes Million Baht % Million Baht % Million Baht % Revenue from program rights 249.87 96.56 327.23 94.63 77.36 30.96 Service income 8.14 3.15 16.25 4.70 8.11 99.63 Sales income
1 ended of March 31, 2020 The operating result for the first 3 months periods of 2020 of the company show a net loss of 6.20 million baht, compare to the same period of previous year which a net loss
Subsidiaries) Total revenue of the consolidated financial statements for Q1/2020 amounted 66.2 million baht compared to Q1/2019 with total revenue of 72.9 million baht, decreased 6.7 million baht or 9.2 percent
million baht compare with performance of the same period of the prior year appear as comprehensive net income 1.29 million baht, increase in net loss from the same period of the prior year 16.63 million
Thai Economy in Q1/FY2018 pushed forward the market’s growth in every aspects, as well as growth of Thai GDP that led to; 1. Increase in Company’s sales around 77.22 million baht or 5.99% comparing to
results that the Company reported net loss for the three-month period ended 31 March 2019 of Baht 15.55 million, net loss decreased by Baht 24.05 million or 61% compared to the same period of last year
13.32 Million Baht, increase of 22.51 Million Baht or 244.98% comparing to the same period last year. Profit to equity holders of the parent is 10.75 million baht increase of 21.90 Million Baht or 196.49
statement, the Company booked a net loss amounting to 24.76 million baht, representing a bigger loss of 14.50 million baht or 141.35% from the net loss of 10.26 million baht booked in the same period of last